Cognition Therapeutics, Inc.
CGTX
$1.80
$0.1911.80%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 39.33M | 10.74M | 16.43M | 25.01M | 22.01M |
| Total Receivables | 1.90M | 6.29M | 4.78M | 2.69M | 3.37M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.16M | 1.21M | 1.66M | 1.86M | 1.45M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 489.00K | 814.00K | -- | -- | -- |
| Total Current Assets | 42.88M | 19.05M | 22.87M | 29.56M | 26.83M |
|
|
|||||
| Total Current Assets | 42.88M | 19.05M | 22.87M | 29.56M | 26.83M |
| Net Property, Plant & Equipment | 512.00K | 573.00K | 634.00K | 679.00K | 749.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 43.40M | 19.62M | 23.50M | 30.23M | 27.58M |
|
|
|||||
| Total Accounts Payable | 827.00K | 771.00K | 1.82M | 1.98M | 1.90M |
| Total Accrued Expenses | 3.92M | 9.37M | 7.71M | 7.62M | 9.51M |
| Short-term Debt | -- | 41.00K | 161.00K | 279.00K | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 168.00K | 198.00K | 194.00K | 193.00K | 188.00K |
| Total Finance Division Other Current Liabilities | 1.74M | 1.98M | 1.07M | 1.07M | 1.12M |
| Total Other Current Liabilities | 1.74M | 1.98M | 1.07M | 1.07M | 1.12M |
| Total Current Liabilities | 6.65M | 12.36M | 10.95M | 11.14M | 12.71M |
|
|
|||||
| Total Current Liabilities | 6.65M | 12.36M | 10.95M | 11.14M | 12.71M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | 41.00K | 161.00K | 279.00K | -- |
| Capital Leases | 212.00K | 229.00K | 280.00K | 342.00K | 392.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 6.87M | 12.59M | 11.23M | 11.48M | 13.10M |
|
|
|||||
| Common Stock & APIC | 231.83M | 197.40M | 195.91M | 193.91M | 181.80M |
| Retained Earnings | -195.30M | -190.37M | -183.64M | -175.16M | -167.32M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 36.53M | 7.03M | 12.27M | 18.75M | 14.48M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 36.53M | 7.03M | 12.27M | 18.75M | 14.48M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 36.53M | 7.03M | 12.27M | 18.75M | 14.48M |
|
|
|||||